The city of Norfolk, Virginia, currently has 13 active clinical trials seeking participants for Lymphoma research studies.
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Recruiting
ELiPSE-1 is a Phase 1, multi-center, dose-finding study to evaluate the safety, pharmacokinetics, and preliminary efficacy of CNTY-101 in participants with relapsed or refractory cluster of differentiation (CD)19-positive B-cell malignancies.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: Virginia Oncology Associates, Norfolk, Virginia
Conditions: R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma